Document is current
Any future updates will be listed below
-
Authors
Nomura, Manami
Sugihara, Takahiko https://orcid.org/0000-0002-7181-7494
Baba, Hiroyuki
Hosoya, Tadashi
Kamiya, Mari
Ishizaki, Tatsuro
Matsumoto, Takumi
Kubo, Kanae
Hirano, Fumio
Kojima, Masayo
Miyasaka, Nobuyuki
Yasuda, Shinsuke
Harigai, Masayoshi
-
Funding
Funding for this research was provided by:
The Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research 26461480)
The Ministry of Health, Labour and Welfare, Japan (22FE0201)
Japan Agency for Medical Research and Development (21ek0410086h0001)
The Japan College of Rheumatology Grant for Promoting Research for FRONTIER (None)
- License Information
-
More Information
Article History
Received: 7 September 2024
Accepted: 29 January 2025
First Online: 3 February 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and the Ethical Guidelines for Epidemiological Research in Japan. The Ethics Committee of Tokyo Metropolitan Geriatric Hospital approved the protocol of this study (240117,467) and all patients provided written informed consent.
: Not applicable.
: TS has received research grants from AsahiKASEI Co., Ltd., Daiichi Sankyo., Chugai Pharmaceutical Co., Ltd., and Ono Pharmaceutical. TS has received honoraria from Abbvie Japan Co., Ltd., AsahiKASEI Co., Ltd., Astellas Pharma Inc., Ayumi Pharmaceutical, Bristol Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Mitsubishi-Tanabe Pharma Co., Ono Pharmaceutical, Pfizer Japan Inc., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd., and UCB Japan Co. Ltd. MKa has received research grants from GlaxoSmithKline. TM has received speakers bureau from AbbVie, AsahiKASEI, Astellas Pharma, Boehringer-Ingelheim, Eisai, Janssen Pharmaceuticals, Mitsubishi Tanabe Pharma, Nippon Shinyaku, and Taisho Pharmaceutical. KK has received research grants from Asahi KASEI. KK has received speakers bureau from Bristol-Myers Squibb, Chugai Pharmaceutical, Astellas Pharma, Mitsubishi Tanabe Pharma, Daiichi-Sankyo, Boehringer-Ingelheim, AbbVie/Abbott, AsahiKASEI, Pfizer, Nippon Shinyaku, Eisai, and Taisho Pharmaceutical. FH has received honoraria from Janssen Pharmaceuticals, Ono Pharmaceuticals, Mitsubishi Tanabe Pharma, Taisho Pharmaceuticals, Boehringer Ingelheim Japan, and Chugai Pharmaceutical. MKo has received speakers bureau from AbbVie, Astellas, Ayumi Pharma, Chugai, Eisai, Eli Lilly, Janssen, Ono Pharmaceutical, Pfizer, Tanabe-Mitsubishi, and Takeda Pharmaceutical Co., Ltd. SY has received research grants from AsahiKASEI Co., Ltd. and Chugai Pharmaceutical Co., Ltd. SY has received honoraria from Abbvie Japan Co., Ltd., AsahiKASEI Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Mitsubishi-Tanabe Pharma Co., Ono Pharmaceutical, Pfizer Japan Inc., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd., and UCB Japan Co. Ltd. MH has received research grants from AbbVie Japan GK, Asahi Kasei Corp., Astellas Pharma Inc., Ayumi Pharmaceutical Co., Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Daiichi-Sankyo, Inc.,Eisai Co., Ltd., Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Nippon Kayaku Co., Ltd., Sekiui Medical, Shionogi & Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. MH has received speaker’s fee from AbbVie Japan GK, Ayumi Pharmaceutical Co., Boehringer Ingelheim Japan, Inc.,Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., GlaxoSmithKline K.K., Kissei Pharmaceutical Co., Ltd., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. MH is a consultant for AbbVie, Boehringer-ingelheim, Bristol Myers Squibb Co., Kissei Pharmaceutical Co.,Ltd. and Teijin Pharma. All other authors (MN, HB, TH, TI and NM) have declared no conflicts of interest. The sponsors were not involved in the study design; in the collection, analysis, and interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication.
